Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Jan 24, 2017 at 12:15 PM EST

4 Speculative Biotech and Biohealth Analyst Upgrades

It seems that analysts are taking the forefront and making calls on where the biopharma industry is going ahead of…

Jon C. Ogg | Jan 24, 2017 at 10:15 AM EST

Despite Pharma Risks, Jefferies Likes 4 Top Contract Research Stocks

The contract research organizations, or CROs, may offer a lot of value as companies look to bring in help from…

Paul Ausick | Jan 24, 2017 at 8:35 AM EST

Johnson & Johnson Revenues, 2017 Outlook Weigh on Shares

Johnson & Johnson offer disappointing 2017 outlook and announce that it is reviewing options, including possible sales, of its diabetes…

Chris Lange | Jan 23, 2017 at 3:42 PM EST

Why This Seizure Drug Matters So Much for Marinus Pharma

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) saw its shares climb on Monday after the company reported positive preliminary results from its…

Chris Lange | Jan 23, 2017 at 12:35 PM EST

Why Credit Suisse Sees Incyte Rising Over 15%

Credit Suisse sees future earnings growth from Incyte’s pipeline, with epacadostat’s potential as a best-in-class immunotherapy combination agent making the…

Chris Lange | Jan 23, 2017 at 11:40 AM EST

Why Credit Suisse Sees 25% Upside at BioMarin

BioMarin Pharmaceutical may have missed out on the Trump rally, but it might not be too late to catch a…

Lee Jackson | Jan 23, 2017 at 9:55 AM EST

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

A new Jefferies research report makes the case that while market parameters are indeed expensive, there still are cheap stocks…

Chris Lange | Jan 19, 2017 at 12:20 PM EST

Thursday’s Top Biopharma Movers

Not that many biotech and pharma companies were on the move Thursday, just one day before the inauguration. However, a…

Lee Jackson | Jan 19, 2017 at 8:40 AM EST

Baird Has 4 Red-Hot Biotechs to Buy for 2017 With Huge Upside Potential

A recent research report from the biotech team at Baird offers their top picks for 2017. While hardly pounding the…

Jon C. Ogg | Jan 18, 2017 at 2:10 PM EST

How Erectile Dysfunction in Mexico Just Made One Micro-Cap Stock More Than Double

The biotechs and emerging pharma have been under pressure from politicians attacking drug prices. That doesn't mean that there are…

Chris Lange | Jan 18, 2017 at 11:05 AM EST

Wednesday’s Top Biopharma Winners

Trump said last week that companies in the health care sector are “getting away with murder,” and that something had…

Trey Thoelcke | Jan 18, 2017 at 7:40 AM EST

What Eli Lilly Gets With CoLucid Acquisition

This acquisition not only will enhance Eli Lilly's existing portfolio in pain management for migraine, but it also adds a…

Paul Ausick | Jan 17, 2017 at 1:05 PM EST

What the FDA Approves — and What It Doesn’t

A product advertised as "FDA-approved" may or may not have been approved by the agency, and, as in almost all…

Chris Lange | Jan 17, 2017 at 11:05 AM EST

Tuesday’s Top Biopharma Movers

A few biotech and pharma companies were on the move Tuesday. A few of the smaller caps made tremendous gains…

Paul Ausick | Jan 17, 2017 at 7:45 AM EST

UnitedHealth Takes Aim at New 52-Week High After Solid Earnings

UnitedHealth Group beats earnings, revenue estimates; on track for new 52-week high.

1 … 176 177 178 179 180 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

4 Speculative Biotech and Biohealth Analyst Upgrades

Despite Pharma Risks, Jefferies Likes 4 Top Contract Research Stocks

Johnson & Johnson Revenues, 2017 Outlook Weigh on Shares

Why This Seizure Drug Matters So Much for Marinus Pharma

Why Credit Suisse Sees Incyte Rising Over 15%

Why Credit Suisse Sees 25% Upside at BioMarin

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

Thursday’s Top Biopharma Movers

Baird Has 4 Red-Hot Biotechs to Buy for 2017 With Huge Upside Potential

How Erectile Dysfunction in Mexico Just Made One Micro-Cap Stock More Than Double

Wednesday’s Top Biopharma Winners

What Eli Lilly Gets With CoLucid Acquisition

What the FDA Approves — and What It Doesn’t

Tuesday’s Top Biopharma Movers

UnitedHealth Takes Aim at New 52-Week High After Solid Earnings

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Health and Healthcare Articles

All Health and Healthcare Articles

4 Speculative Biotech and Biohealth Analyst Upgrades

Despite Pharma Risks, Jefferies Likes 4 Top Contract Research Stocks

Johnson & Johnson Revenues, 2017 Outlook Weigh on Shares

Why This Seizure Drug Matters So Much for Marinus Pharma

Why Credit Suisse Sees Incyte Rising Over 15%

Why Credit Suisse Sees 25% Upside at BioMarin

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

Thursday’s Top Biopharma Movers

Baird Has 4 Red-Hot Biotechs to Buy for 2017 With Huge Upside Potential

How Erectile Dysfunction in Mexico Just Made One Micro-Cap Stock More Than Double

Wednesday’s Top Biopharma Winners

What Eli Lilly Gets With CoLucid Acquisition

What the FDA Approves — and What It Doesn’t

Tuesday’s Top Biopharma Movers

UnitedHealth Takes Aim at New 52-Week High After Solid Earnings

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check